BiotechTube
Home/Surmodics/Andrew D. C. LaFrence
AD

Andrew D. C. LaFrence

Senior Vice President, Technology and Innovation

Surmodics

Therapeutic Areas

Peripheral Arterial DiseaseVenous ThromboembolismVascular Access

Surmodics Pipeline

DrugIndicationPhase
Pounce™ Arterial Thrombectomy SystemPeripheral Arterial Thrombosis/EmbolismCommercial
Pounce™ Venous Thrombectomy SystemPeripheral Venous ThrombosisCommercial
Sublime™ Radial Access PlatformRadial Access for Peripheral InterventionCommercial
Preside™ Hydrophilic CoatingsDevice Lubricity for Neuro/Coronary/PeripheralCommercial & Development
Drug-Coated Balloon (DCB) TechnologyVascular Drug DeliveryDevelopment/Partnership

Leadership Team at Surmodics

GM
Gary Maharaj
President and Chief Executive Officer
TJ
Timothy J. Arens
Senior Vice President, CFO and Treasurer
JL
Joseph L. Stich
Senior Vice President, General Counsel and Secretary
BK
Bryan K. Phillips
Senior Vice President, Corporate and Business Development
BR
Brian R. Jablonski
Senior Vice President, Global Sales and Marketing, Medical Device
View full Surmodics profile